Are predictive treatment analytics actually used in clinics yet?

If you listen to the industry hype, predictive treatment analytics sounds like a medical crystal ball. We are often told that AI will soon predict which patient will respond to which medication before they even step into a consultation room. But as someone who has spent the last decade working between NHS-adjacent vendors and private digital clinics, the reality is far more grounded—and, frankly, much more complex.

In clinical practice, "predictive" doesn't mean "automated decision-making." It means using data to signal to a clinician that a patient requires an earlier review, a dosage adjustment, or a change in care pathway. It is about augmenting clinical judgement, not replacing it.

To understand where we actually are, we have to look past the marketing and https://stackademic.com/blog/the-technology-reshaping-uk-medical-cannabis-services map the journey of a patient engaging with modern digital healthcare services.

The patient journey: Mapping the digital entry point

The patient journey is not a frictionless e-commerce funnel. When we talk about telehealth and online eligibility forms, we are dealing with regulated workflows that carry real clinical risks. The following table maps the standard digital clinical pathway as it exists today.

image

Stage Primary Function Key Constraint Digital Entry Discovery and service initiation Compliance with advertising standards Eligibility Screening Asynchronous data collection Clinical safety logic (not just UX) Consultation Synchronous/Asynchronous video/chat GMC/NMC registration and patient ID Prescription E-script issuance Governance and formulary restrictions Treatment Monitoring Patient dashboard reporting Adherence tracking and safety alerts

1. The entry point: Telehealth and eligibility

Telehealth is now the default entry point for many private services, particularly in dermatology, mental health, and sexual health. However, the "onboarding" process is where most healthtech product teams get it wrong. They treat the sign-up form like a registration for a streaming service.

In a clinical context, the eligibility form is the first gatekeeper. It must be designed to capture high-fidelity medical history. If the form is poorly designed, we get "garbage in, garbage out," which makes predictive analytics impossible. You cannot predict treatment efficacy if your underlying data (e.g., patient-reported outcome measures) is biased or incomplete.

The pricing transparency trap

One of the most frequent friction points is the opaque nature of costs. Patients often progress through an eligibility form, only to be hit with unexpected consultation fees or delivery charges at the point of checkout. This isn't just bad UX; it creates a barrier to honest clinical engagement. Product teams should ensure that all pricing structures, including consultations and medication delivery, are displayed transparently before a patient commits to a clinical history. Providers should look at clear, dedicated pricing pages rather than burying fees in a checkout modal.

2. Treatment monitoring and the dashboard reality

This is where we find the "predictive" element. In the current landscape, this usually manifests as patient dashboards. These dashboards allow a patient to input symptoms or side effects periodically.

The "predictive" part of this is essentially high-end threshold alerting. If a patient indicates their symptoms are worsening or their side effects exceed a pre-defined severity score, the system flags this for a clinician’s intervention. It is not an algorithm "deciding" a new treatment; it is a clinical governance tool that ensures a human gets involved when the data deviates from the expected norm.

True predictive analytics—using longitudinal data to forecast treatment response—is still in its infancy in the private clinic sector. We are currently building the data lakes required to train those models, but we are not yet at the stage where these models drive routine clinical practice autonomously.

3. Governance: Security and confidentiality

If you see a product deck claiming "bank-level encryption," stop and ask for a detailed security posture document. In healthcare, "bank-level" means nothing. We need to talk about ISO 27001 standards, Cyber Essentials Plus, and strict adherence to GDPR and the Data Protection Act 2018.

When patients upload medical records—such as summary care records or historical lab results—that data must be encrypted in transit and at rest, but more importantly, it must be subject to strict access controls. Only the clinician responsible for the care episode should have access to these documents. Predictive analytics can only exist if we can ensure patient confidentiality is managed through rigorous RBAC (Role-Based Access Control) systems.

4. The "What could go wrong" checklist for product teams

Before launching a new feature in a digital clinic, I always run through a failure-mode checklist. If you are building for clinical environments, these are the risks that keep compliance officers up at night:

    Onboarding Failure: Does the eligibility form trigger a "hard stop" when a patient reports a contraindication, or does it allow them to proceed to a consultation anyway? E-prescription Governance: Is there a secondary verification step for controlled medications, or is it a single-point-of-failure workflow? Renewal Drift: Do automated renewals happen without a clinical review, effectively "ghosting" the patient’s health status? Data Silos: Does the patient dashboard data actually sync back to the clinician’s view, or is it trapped in an isolated database? Transparency Gaps: Are patients forced to input private medical data before seeing the full cost of the consultation?

The future of healthtech: Beyond the hype

Predictive treatment analytics will eventually play a larger role in clinical efficiency, but it will happen in the background. It will look like better triaging, more accurate dose titration, and earlier detection of treatment failure.

We are currently in a transition period. We have moved away from the "e-commerce" mindset—where the goal is conversion at all costs—and toward a "clinical safety" mindset. The future of healthtech isn't about using AI to bypass the clinician; it’s about using technology to provide the clinician with a clearer, more data-driven picture of the patient's progress.

image

Final thoughts for product teams

Be honest about your AI: If your "predictive model" is a set of if-then-else rules, admit it. Clinicians will respect you more for being transparent about your logic. Prioritise the user's pocketbook: Transparency in pricing isn't a "nice to have." It is a fundamental part of the patient journey. Point users to your pricing pages early and often. Focus on the workflow, not the bells and whistles: A dashboard that is beautiful but disconnected from the clinician’s workflow is useless. Ensure your data feeds directly into the patient record to allow for seamless clinical review.

We are in a fortunate position to shape how digital healthcare matures. If we avoid the temptation to overpromise and instead focus on rigorous, safe, and transparent digital workflows, we can actually make a measurable difference in patient outcomes. That is the only type of "future healthtech" worth building.